| Phenylacetaldehyde is an organic compound used in the synthesis of fragrances and polymers. Phenylacetaldehyde is an aldehyde that consists of acetaldehyde bearing a phenyl substituent; the parent member of the phenylacetaldehyde class of compounds. It has a role as a human metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is an alpha-CH2-containing aldehyde and a member of phenylacetaldehydes.
Phenylacetaldehyde is one important oxidation-related aldehyde. Exposure to styrene gives phenylacetaldehyde as a secondary metabolite. Styrene has been implicated as reproductive toxicant, neurotoxicant, or carcinogen in vivo or in vitro. Phenylacetaldehyde could be formed by diverse thermal reactions during the cooking process together with C8 compounds is identified as a major aroma–active compound in cooked pine mushroom. Phenylacetaldehyde is readily oxidized to phenylacetic acid. Therefore will eventually be hydrolyzed and oxidized to yield phenylacetic acid that will be excreted primarily in the urine in conjugated form. |
|
Read full article at Wikipedia
|
| InChI=1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14) |
| KPYSYYIEGFHWSV-UHFFFAOYSA-N |
|
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
|
GABA agonist
A drug that binds to and activates gamma-aminobutyric acid receptors.
|
|
|
muscle relaxant
A drug used to produce muscle relaxation (excepting neuromuscular blocking agents). Its primary clinical and therapeutic use is the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. Also used for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in multiple sclerosis.
central nervous system depressant
A loosely defined group of drugs that tend to reduce the activity of the central nervous system.
GABA agonist
A drug that binds to and activates gamma-aminobutyric acid receptors.
|
|
View more via ChEBI Ontology
|
4-amino-3-(4-chlorophenyl)butanoic acid
|
|
baclofen
|
WHO MedNet
|
baclofène
|
WHO MedNet
|
baclofeno
|
WHO MedNet
|
baclofenum
|
WHO MedNet
|
|
(+-)-Baclofen
|
ChemIDplus
|
|
4-Amino-3-(4-chlorophenyl)butyric acid
|
ChemIDplus
|
|
beta-(4-Chlorophenyl)gaba
|
ChemIDplus
|
|
beta-(Aminomethyl)-4-chlorobenzenepropanoic acid
|
ChemIDplus
|
|
beta-(Aminomethyl)-p-chlorohydrocinnamic acid
|
ChemIDplus
|
|
beta-(p-Chlorophenyl)-gamma-aminobutyric acid
|
ChemIDplus
|
|
DL-4-Amino-3-p-chlorophenylbutanoic acid
|
ChemIDplus
|
|
DL-Baclofen
|
ChemIDplus
|
|
gamma-Amino-beta-(p-chlorophenyl)butyric acid
|
ChemIDplus
|
|
1134-47-0
|
CAS Registry Number
|
ChemIDplus
|
|
1134-47-0
|
CAS Registry Number
|
NIST Chemistry WebBook
|
|
2104494
|
Reaxys Registry Number
|
Reaxys
|
|
11772961
|
PubMed citation
|
Europe PMC
|
|
18682277
|
PubMed citation
|
Europe PMC
|
|
18824012
|
PubMed citation
|
Europe PMC
|
|
